Babban nauyin tumor, immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H

An yarda da Pembrolizumab don amfani da ita a cikin kowace cutar kansa tare da babban nauyin maye gurbi

Yuli 2021: Hukumar Abinci da Magunguna ta Amurka (FDA) ta faɗaɗa alamun pembrolizumab (Keytruda), maganin rigakafi, don haɗa kowane ciwon daji tare da babban nauyin maye gurbin (TMB-H). Sabuwar izini shine f..

An gano wanda ya sake kamuwa da cutar sankarar mafitsara "MLL gene"

Tawagar binciken na asibitin Shenzhen sun tattara samfuran 37 na masu cutar kansar mafitsara, sun gudanar da cikakken tsari da dabarun gyara kwayar halitta, kuma sun gano mai laifin sake kamuwa da cutar sankarar mafitsara- "MLL gene" .A na bakwai, th ..

Akalabrutunib, Avelumab, CART far, Dabrafanib, Kimiya, Sabbin magunguna, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA

Sabbin magunguna na maganin cutar kansa

Yuli 2021: Duba sabbin magunguna a cikin maganin cutar kansa. Kowace shekara, bayan nazarin gwaje-gwajen da wasu muhimman abubuwa, USFDA ta amince da kwayoyi, don haka masu ciwon daji za su iya gaskata cewa magani ya kusa. ..